AJMC Staff

Posters focus on next-generation sequencing ovarian cancer and identify candidates for treatment with PARP inhibitors.

The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.

The collaboration will make available 3 fully-humanized monoclonal antibodies to fight the devastating virus.

As enrollment in Medicare Advantage is expected to increase to a new all-time high for the sixth year in a row, CMS announced that Medicare Advantage premiums will remain stable in 2016.

An analysis of the competitive landscape of the public health insurance exchanges as it has so far unfolded has revealed that despite challenges to date, the exchanges have been attracting new entrants.

Work at the Karolinska Institutet has revealed a potential new therapeutic target in type 2 diabetes.

Nearly half a billion dollars in Affordable Care Act funding will be awarded to health centers around the country to help them provide primary care services to those who need them most.

The American Society of Clinical Oncology has urged Congress to recognize the impact of barriers to interoperability of electronic health records on patient outcomes.

Researchers analyzed patient records from a 25-year period and found risks increased with higher doses and longer periods of treatment.

Unaccounted for social and clinical characteristics of a hospital's patient population explain nearly half of the difference in readmission rates between the best and the worst performing hospitals when it comes to Medicare penalties for hospital readmission rates.

Although a new report from The Commonwealth Fund raised concerns about the competition of Medicare Advantage (MA) programs available across the country, a new analysis from Avalere Health found that there has been a growing number of MA plan options for consumers.

Over 10 million personal records of Excellus BlueCross BlueShield customers were jeopardized when hackers gained access to the health plan's database.

FDA has warned that the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling. In a statement, the FDA said said it had issued a "warning and precaution" to all labels in this drug class.

Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed.

Predictive modeling determined that the needle exchange in Washington, DC, prevented 120 new cases of HIV in 2 years, according to researchers.

Rolapitant was approved to prevent delayed phase chemotherapy-induced nausea and vomiting in adult patients.

Approval for the technology, which integrates with a smartphone, came sooner than company officials expected.

Pharmacy cost trends are expected to increase 10% up from 6.3% the year before, with specialty pharmacy trends experiencing the largest increases, according to a survey from Aon Health.

Although the fee-for-service model of reimbursement has been blamed as an reason for high healthcare costs in America, a report from HealthPocket found that eliminating this payment model in provider-owned health plans did not produce the cheapest health plans.

A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.

Fears of health insurance premium hikes during the third year of the Affordable Care Act may not be unfounded. In Tennessee, the state's insurance commissioner just approved BlueCross BlueShield of Tennessee's 36.3% increase.

Alaska Governor Bill Walker (I) announced in July that he would expand Medicaid in his state despite the legislature's decision to block his efforts, and now the Republican-controlled body is suing him.

Semaglutide is currently available as an injectible only, but the company is working on a once-daily pill form.

A prominent neuroscientist has developed the Quick Dementia Rating System to reliably, and quickly, identify patients suffering from dementia.

States that are unable to accelerate their efforts to slow Medicaid spending will face long-term budget imbalances, according to a new report from Fitch Ratings.

An immunotherapy developed by Amgen and approved by the FDA for the treatment of acute lymhoblastic leukemia in December 2014 has now received coverage assurance from Medicare, following an initial rejection.

The approach for assessing hospital penalties under the Hospital-Acquired Condition Reduction Program might need to be reconsidered in order to achieve the intended goal of the program.

The network, PEDSnet, combines big data from electronic health records with family engagement

Households that received financial help for health insurance under the Affordable Care Act are now having tax return issues, which could jeopardize their eligibility for subsidies next year.

Safety net hospitals in California are using a car manufacturer's model to improve efficiency while saving on care costs.